Thyroid Cancer Diagnostics Market Report 2026

Thyroid Cancer Diagnostics Market Overview

• Thyroid Cancer Diagnostics market size has reached to $3.15 billion in 2025 • Expected to grow to $4.25 billion in 2030 at a compound annual growth rate (CAGR) of 6.2% • Growth Driver: The Surge In Thyroid Cancer Prevalence And Its Implications On The Diagnostic Market • Market Trend: Innovative RNA Sequencing Enhances Accuracy In Diagnosing Thyroid Cancer Fusions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Thyroid Cancer Diagnostics Market?

Thyroid cancer diagnostics refers to a technique to test a lump or nodule responsible for thyroid cancer present in the body and helps in diagnosing thyroid cancer. Thyroid cancer refers to a type of cancer that starts in the thyroid gland when cells begin to grow out of control. The main techniques in thyroid cancer diagnostics are imaging tests, blood tests, biopsies, and others. Imaging refers to the process of creating images that depict phenomena such as temperature, sound waves, chemicals, or electrical activity. Imaging tests are used in thyroid cancer diagnostics to produce images of the thyroid gland. The various disease types include papillary carcinoma, follicular carcinoma, and others. These are used by various end-users such as hospital laboratories, cancer diagnostic centers, research institutes, and others.

What Is The Thyroid Cancer Diagnostics Market Growth Forecast?

The thyroid cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.25 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing adoption of ai-assisted imaging diagnostics, rising demand for personalized oncology diagnostics, expansion of molecular testing panels, growing investments in early cancer screening, increasing focus on precision diagnostics. Major trends in the forecast period include increasing use of molecular diagnostic techniques, rising adoption of imaging-based screening, growing integration of genetic testing, expansion of early detection programs, enhanced diagnostic accuracy and speed.

Global Thyroid Cancer Diagnostics Market Segmentation

1) By Technique Type: Imaging Test, Blood Test, Biopsy, Other Test Types 2) By Disease Type: Papillary Carcinoma, Follicular Carcinoma, Other Diseases 3) By End-User: Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users Subsegments: 1) By Imaging Test: Ultrasound Imaging, Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans, Radioactive Iodine Scans 2) By Blood Test: Thyroid Function Tests, Tumor Marker Tests, Genetic Testing For Thyroid Cancer 3) By Biopsy: Fine Needle Aspiration (FNA) Biopsy, Core Needle Biopsy, Surgical Biopsy 4) By Other Test Type: Molecular Diagnostics, Immunohistochemistry Tests, Histopathological Analysis

What Is The Driver Of The Thyroid Cancer Diagnostics Market?

The increasing prevalence of thyroid cancer is driving the growth of the thyroid cancer diagnostic market going forward. Thyroid cancer is a disease in the thyroid gland (a gland near the base of the throat that produces hormones to help regulate body temperature, heart rate, blood pressure, and weight). Thyroid cancer diagnostics help to discover thyroid cancer by providing early detection that can help improve treatment outcomes. Thus, the increasing prevalence of thyroid cancer increases the demand for the diagnostic market. For instance, in September 2023, according to a report published by the American Cancer Society, a US-based non-profit organization, there are anticipated to be approximately 43,720 new cases of thyroid cancer, with 12,540 occurring in men and 31,180 in women in 2023. The projected number of deaths from thyroid cancer in the same year is around 2,120, with 970 in men and 1,150 in women. Therefore, thyroid cancer's increasing prevalence is propelling the diagnostic market of thyroid cancer.

Key Players In The Global Thyroid Cancer Diagnostics Market

Major companies operating in the thyroid cancer diagnostics market are General Electric, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Toshiba Corporation, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Agilent Technologies Inc., Hologic Inc., Illumina Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., Qiagen N.V., Cepheid, Veracyte Inc., DiaSorin S.p.A., Myriad Genetics Inc., Interpace Biosciences, Guardant Health, BillionToOne, Canon Inc., Beckman Coulter Inc.

Global Thyroid Cancer Diagnostics Market Trends and Insights

Major companies operating in the thyroid cancer diagnostic market are developing innovative solutions such as RNA sequencing test to enhance the accuracy of cancer fusion detection across multiple solid tumors, including thyroid cancer. RNA sequencing (RNA-Seq) is a high-throughput technique that enables the analysis of the quantity and sequence of RNA in a sample, providing insights into gene expression and the overall transcriptome. For instance, in May 2024, Foundation Medicine, Inc. a US-based biotechnology company announced the U.S. launch of FoundationOne RNA, a tissue-based RNA sequencing test designed to detect cancer-related gene fusions across 318 genes. This test provides fusion reporting for all solid tumors and may be particularly useful in identifying fusions in cancers like non-small cell lung cancer (NSCLC), sarcoma, pancreatic cancer, thyroid cancer, cholangiocarcinoma, and bladder cancer.

What Are Latest Mergers And Acquisitions In The Thyroid Cancer Diagnostics Market?

In September 2024, The World Tumor Registry (WTR), a US-based non-profit organization dedicated to the collection and analysis of tumor data, partnered with PathPresenter. This partnership aligns with WTR's mission to create an accessible educational resource for cancer care and research organizations worldwide, providing a secure and scalable solution to enhance cancer diagnostics and education. PathPresenter, a US-based multi-tenant enterprise pathology workflow software platform.

Regional Outlook

North America was the largest region in the thyroid cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Thyroid Cancer Diagnostics Market?

The thyroid cancer diagnostics market includes revenues earned by entities by providing diagnostic tools related detection and diagnosis of thyroid cancer, radioactive tracer, biopsy, blood tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Thyroid Cancer Diagnostics Market Report 2026?

The thyroid cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the thyroid cancer diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.